While Jan. 1 means sleeping off a campagne-induced hangover for many, for drug-price wonks, it means an opportunity to look at price-change behavior in the pharmaceutical market, as January is traditionally the month where most list-priceadjustments happen.  

Antonio Ciaccia from 46Brooklyn and 3Axis Advisors, looks as closely at the data as anyone -- his Brand Drug Boxscore is required reading -- and has a good sense of the few times should care about list price changes, as well the many reasons why focusing too much on list price increases is ill-advised. 

He joins us this month to get into the truths and the asterisks of talking about the January price-hike tradition.